Updated Prevalence of Lymphangioleiomyomatosis in Europe
Am J Respir Crit Care Med
.
2024 Feb 15;209(4):456-459.
doi: 10.1164/rccm.202310-1736LE.
Authors
Evelyn Lynn
1
2
,
Sarah H Forde
2
,
Alessandro N Franciosi
1
2
,
Elisabeth Bendstrup
3
4
,
Marcel Veltkamp
5
6
,
Anne E Wind
5
,
Coline H M Van Moorsel
5
,
Thomas Kromann Lund
7
,
Michael Thomas Durheim
8
9
,
Evelien F H I Peeters
10
,
Michael P Keane
1
2
,
Cormac McCarthy
1
2
;
Northern European LAM Prevalence Consortium
Collaborators
Northern European LAM Prevalence Consortium
:
Marissa O'Callaghan
,
Amina Jouida
,
Adriane D M Vorselaars
,
Michael Perch
Affiliations
1
Department of Respiratory Medicine, St. Vincent's University Hospital, Dublin, Ireland.
2
School of Medicine, University College Dublin, Dublin, Ireland.
3
Center for Rare Lung Diseases, Department of Respiratory Disease and Allergy, Aarhus University Hospital, Aarhus, Denmark.
4
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
5
ILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands.
6
Division of Heart and Lungs and.
7
Section for Lung Transplantation, Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
8
Department of Respiratory Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and.
9
Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
10
Department of Internal Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
PMID:
38060201
DOI:
10.1164/rccm.202310-1736LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Europe / epidemiology
Humans
Lung Neoplasms* / epidemiology
Lymphangioleiomyomatosis* / epidemiology
Prevalence
Tuberous Sclerosis*
Grants and funding
CTN-2021-009/HRB Ireland
LAM0144SG01-20/LAM Foundation